Gujarat Inject Kerala vs LAURUS LABS LIMITED

A side-by-side comparison of Gujarat Inject Kerala (GUJINJEC) and LAURUS LABS LIMITED (LAURUSLABS) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, LAURUS LABS LIMITED leads GUJINJEC vs LAURUSLABS on 9 of 14 metrics (2 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability04
  • Growth· not comparable—
  • Size & financial health13
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

53.25
P/E ratio
94.20
0.00
P/B ratio
20.84
0.00%
Dividend yield
0.09%
₹0.20
EPS
₹16.47

Profitability

LAURUSLABS takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

10.16%
Return on equity
16.77%
12.54%
Return on capital
17.58%
0.00%
EBITDA margin
26.09%
6.43%
Net margin
13.07%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

—
Revenue CAGR (3Y) even
4.09%
—
Profit CAGR (3Y) even
3.91%

Size & financial health

LAURUSLABS takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹152 Cr
Market cap
₹1.26L Cr
₹0 Cr
Revenue
₹6,813 Cr
₹0 Cr
Net profit
₹890 Cr
0.00
Debt / equity
0.45
LAURUS LABS LIMITED
  • + []
  • − ["Stock is trading at 23.83 times its book value", "The company has delivered a poor sales growth of 7.2% over past five years.", "The company has delivered a poor profit growth of -2.0% over past five years."]
Gujarat Inject Kerala full analysis LAURUS LABS LIMITED full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.